A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis

NCT01142583 · clinicaltrials.gov ↗

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Sponsor

Merck KGaA, Darmstadt, Germany